annual CFI:
-$116.84M+$219.51M(+65.26%)Summary
- As of today (May 29, 2025), ALNY annual cash flow from investing activities is -$116.84 million, with the most recent change of +$219.51 million (+65.26%) on December 31, 2024.
- During the last 3 years, ALNY annual CFI has risen by +$156.46 million (+57.25%).
- ALNY annual CFI is now -142.81% below its all-time high of $272.94 million, reached on December 31, 2018.
Performance
ALNY Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$113.77M+$166.68M(+315.02%)Summary
- As of today (May 29, 2025), ALNY quarterly cash flow from investing activities is $113.77 million, with the most recent change of +$166.68 million (+315.02%) on March 31, 2025.
- Over the past year, ALNY quarterly CFI has increased by +$181.39 million (+268.25%).
- ALNY quarterly CFI is now -63.76% below its all-time high of $313.89 million, reached on September 30, 2022.
Performance
ALNY quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$64.55M+$181.39M(+155.25%)Summary
- As of today (May 29, 2025), ALNY TTM cash flow from investing activities is $64.55 million, with the most recent change of +$181.39 million (+155.25%) on March 31, 2025.
- Over the past year, ALNY TTM CFI has increased by +$392.30 million (+119.69%).
- ALNY TTM CFI is now -87.35% below its all-time high of $510.41 million, reached on March 31, 2019.
Performance
ALNY TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ALNY Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.3% | +268.3% | +119.7% |
| 3 y3 years | +57.3% | +177.2% | +113.1% |
| 5 y5 years | +72.0% | +0.1% | +115.9% |
ALNY Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -169.0% | +65.3% | -63.8% | +147.3% | -73.2% | +112.8% |
| 5 y | 5-year | -169.0% | +73.2% | -63.8% | +125.8% | -73.2% | +111.6% |
| alltime | all time | -142.8% | +78.7% | -63.8% | +125.8% | -87.3% | +111.6% |
ALNY Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $113.77M(-315.0%) | $64.55M(-155.2%) |
| Dec 2024 | -$116.84M(-65.3%) | -$52.91M(+74.9%) | -$116.84M(-61.6%) |
| Sep 2024 | - | -$30.25M(-189.1%) | -$304.59M(+6.8%) |
| Jun 2024 | - | $33.94M(-150.2%) | -$285.10M(-13.0%) |
| Mar 2024 | - | -$67.62M(-71.9%) | -$327.75M(-2.6%) |
| Dec 2023 | -$336.35M(-298.6%) | -$240.66M(+2135.7%) | -$336.35M(+42.8%) |
| Sep 2023 | - | -$10.76M(+23.5%) | -$235.60M(-364.6%) |
| Jun 2023 | - | -$8.71M(-88.6%) | $89.05M(-63.0%) |
| Mar 2023 | - | -$76.22M(-45.5%) | $240.56M(+42.0%) |
| Dec 2022 | $169.35M(-162.0%) | -$139.91M(-144.6%) | $169.35M(-262.6%) |
| Sep 2022 | - | $313.89M(+119.8%) | -$104.14M(-79.4%) |
| Jun 2022 | - | $142.79M(-196.9%) | -$506.30M(+2.9%) |
| Mar 2022 | - | -$147.42M(-64.3%) | -$492.07M(+80.0%) |
| Dec 2021 | -$273.30M(-37.2%) | -$413.40M(+368.3%) | -$273.30M(-747.4%) |
| Sep 2021 | - | -$88.27M(-156.2%) | $42.22M(-64.9%) |
| Jun 2021 | - | $157.02M(+120.1%) | $120.40M(-125.2%) |
| Mar 2021 | - | $71.35M(-172.9%) | -$477.85M(+9.7%) |
| Dec 2020 | -$435.52M(+4.3%) | -$97.89M(+870.3%) | -$435.52M(-22.0%) |
| Sep 2020 | - | -$10.09M(-97.7%) | -$558.48M(+0.0%) |
| Jun 2020 | - | -$441.23M(-488.1%) | -$558.47M(+37.3%) |
| Mar 2020 | - | $113.69M(-151.5%) | -$406.64M(-2.6%) |
| Dec 2019 | -$417.68M(-253.0%) | -$220.85M(+2091.6%) | -$417.68M(-901.1%) |
| Sep 2019 | - | -$10.08M(-96.5%) | $52.14M(-67.1%) |
| Jun 2019 | - | -$289.40M(-381.9%) | $158.39M(-69.0%) |
| Mar 2019 | - | $102.65M(-58.8%) | $510.41M(+87.0%) |
| Dec 2018 | $272.94M(-194.0%) | $248.96M(+158.9%) | $272.94M(-299.8%) |
| Sep 2018 | - | $96.17M(+53.6%) | -$136.61M(-63.1%) |
| Jun 2018 | - | $62.62M(-146.4%) | -$369.96M(-26.0%) |
| Mar 2018 | - | -$134.81M(-16.0%) | -$500.25M(+72.3%) |
| Dec 2017 | -$290.36M(-303.6%) | -$160.59M(+17.1%) | -$290.36M(+888.2%) |
| Sep 2017 | - | -$137.18M(+102.7%) | -$29.38M(-138.5%) |
| Jun 2017 | - | -$67.67M(-190.1%) | $76.39M(-23.4%) |
| Mar 2017 | - | $75.08M(-25.2%) | $99.73M(-30.1%) |
| Dec 2016 | $142.59M(-144.4%) | $100.39M(-419.7%) | $142.59M(+18.4%) |
| Sep 2016 | - | -$31.41M(-29.2%) | $120.47M(-39.9%) |
| Jun 2016 | - | -$44.34M(-137.6%) | $200.55M(+45.4%) |
| Mar 2016 | - | $117.94M(+50.7%) | $137.95M(-142.9%) |
| Dec 2015 | -$321.32M(-41.5%) | $78.27M(+60.8%) | -$321.32M(-15.0%) |
| Sep 2015 | - | $48.67M(-145.5%) | -$378.16M(-2.8%) |
| Jun 2015 | - | -$106.94M(-68.7%) | -$388.92M(-23.8%) |
| Mar 2015 | - | -$341.33M(-1692.4%) | -$510.36M(-7.0%) |
| Dec 2014 | -$548.81M | $21.43M(-43.5%) | -$548.81M(+6.7%) |
| Sep 2014 | - | $37.91M(-116.6%) | -$514.20M(-7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$228.38M(-39.9%) | -$554.61M(+46.2%) |
| Mar 2014 | - | -$379.78M(-777.6%) | -$379.44M(+190.8%) |
| Dec 2013 | -$130.50M(-3968.0%) | $56.05M(-2338.3%) | -$130.50M(-8.8%) |
| Sep 2013 | - | -$2.50M(-95.3%) | -$143.04M(+16.6%) |
| Jun 2013 | - | -$53.21M(-59.3%) | -$122.68M(+98.3%) |
| Mar 2013 | - | -$130.84M(-400.7%) | -$61.87M(-1933.8%) |
| Dec 2012 | $3.37M(-95.9%) | $43.51M(+143.7%) | $3.37M(-117.4%) |
| Sep 2012 | - | $17.85M(+134.9%) | -$19.36M(+1922.5%) |
| Jun 2012 | - | $7.60M(-111.6%) | -$957.00K(-83.8%) |
| Mar 2012 | - | -$65.59M(-415.6%) | -$5.92M(-107.2%) |
| Dec 2011 | $81.96M(+359.5%) | $20.78M(-42.7%) | $81.96M(-24.6%) |
| Sep 2011 | - | $36.25M(+1274.7%) | $108.75M(+40.9%) |
| Jun 2011 | - | $2.64M(-88.2%) | $77.19M(+62.2%) |
| Mar 2011 | - | $22.29M(-53.2%) | $47.59M(+166.8%) |
| Dec 2010 | $17.84M(+23.6%) | $47.58M(+915.8%) | $17.84M(-31.1%) |
| Sep 2010 | - | $4.68M(-117.4%) | $25.88M(-395.4%) |
| Jun 2010 | - | -$26.96M(+261.3%) | -$8.76M(-67.7%) |
| Mar 2010 | - | -$7.46M(-113.4%) | -$27.15M(-288.1%) |
| Dec 2009 | $14.43M(-19.5%) | $55.62M(-285.7%) | $14.43M(-138.2%) |
| Sep 2009 | - | -$29.95M(-34.0%) | -$37.79M(-14.7%) |
| Jun 2009 | - | -$45.36M(-232.9%) | -$44.28M(-8.1%) |
| Mar 2009 | - | $34.13M(+904.0%) | -$48.18M(-368.6%) |
| Dec 2008 | $17.94M(-106.5%) | $3.40M(-109.3%) | $17.94M(-124.5%) |
| Sep 2008 | - | -$36.45M(-26.0%) | -$73.15M(-63.9%) |
| Jun 2008 | - | -$49.26M(-149.1%) | -$202.59M(+59.1%) |
| Mar 2008 | - | $100.24M(-214.3%) | -$127.33M(-54.1%) |
| Dec 2007 | -$277.43M(+823.3%) | -$87.69M(-47.1%) | -$277.43M(+42.6%) |
| Sep 2007 | - | -$165.89M(-737.9%) | -$194.58M(+632.4%) |
| Jun 2007 | - | $26.00M(-152.2%) | -$26.57M(-60.5%) |
| Mar 2007 | - | -$49.85M(+930.2%) | -$67.19M(+123.6%) |
| Dec 2006 | -$30.05M(-25.7%) | -$4.84M(-328.4%) | -$30.05M(-58.5%) |
| Sep 2006 | - | $2.12M(-114.5%) | -$72.42M(+3.4%) |
| Jun 2006 | - | -$14.62M(+15.0%) | -$70.07M(+34.2%) |
| Mar 2006 | - | -$12.71M(-73.1%) | -$52.22M(+29.2%) |
| Dec 2005 | -$40.42M(+16.8%) | -$47.21M(-1155.3%) | -$40.42M(-624.0%) |
| Sep 2005 | - | $4.47M(+38.5%) | $7.71M(-166.0%) |
| Jun 2005 | - | $3.23M(-455.7%) | -$11.70M(-65.0%) |
| Mar 2005 | - | -$908.00K(-198.9%) | -$33.43M(-3.4%) |
| Dec 2004 | -$34.59M(+967.7%) | $918.00K(-106.1%) | -$34.59M(-2.6%) |
| Sep 2004 | - | -$14.94M(-19.3%) | -$35.51M(+72.6%) |
| Jun 2004 | - | -$18.51M(+793.1%) | -$20.58M(+893.1%) |
| Mar 2004 | - | -$2.07M | -$2.07M |
| Dec 2003 | -$3.24M(+476.5%) | - | - |
| Dec 2002 | -$562.00K | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual CFI year-on-year change?
- What is Alnylam Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly CFI year-on-year change?
- What is Alnylam Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM CFI year-on-year change?
What is Alnylam Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ALNY is -$116.84M
What is the all time high annual CFI for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual cash flow from investing activities is $272.94M
What is Alnylam Pharmaceuticals annual CFI year-on-year change?
Over the past year, ALNY annual cash flow from investing activities has changed by +$219.51M (+65.26%)
What is Alnylam Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ALNY is $113.77M
What is the all time high quarterly CFI for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly cash flow from investing activities is $313.89M
What is Alnylam Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ALNY quarterly cash flow from investing activities has changed by +$181.39M (+268.25%)
What is Alnylam Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ALNY is $64.55M
What is the all time high TTM CFI for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM cash flow from investing activities is $510.41M
What is Alnylam Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ALNY TTM cash flow from investing activities has changed by +$392.30M (+119.69%)